ImmunoACT, Mango Sciences Partner for Affordable CAR-T Therapy
ImmunoACT partners with Mango Sciences to offer zero-interest EMI and outcome-based rebates for its CAR-T therapy NexCAR19, making leukemia and lymphoma treatment more accessible in India.